8-K 1 d8k.txt FORM 8-K ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ------------------ FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ------------------ Date of Report (Date of earliest event reported): February 7, 2002 ------------------- VIDAMED, INC. (Exact name of registrant as specified in its charter) Delaware 0-26082 77-0314454 (State or Other Jurisdiction of (Commission File Number) (I.R.S. Employer Incorporation) Identification Number) 46107 Landing Parkway Fremont, California 94538 (Address of Principal Executive Offices) (Zip Code) (510) 492-4900 (Registrant's Telephone Number, Including Area Code) N/A (Former Name or Former Address, If Changed Since Last Report) ================================================================================ Item 5. Other Events On February 7, 2002, VidaMed, Inc. issued a press release announcing its results for the fourth quarter and fiscal year ended December 31, 2001. A copy of the press release is attached to this report as Exhibit 99.1 and is incorporated herein by this reference. Item 7. Financial Statements and Exhibits. (c) Exhibits. Exhibit No. Description ---------- ------------------------------------------------------ 99.1 Press Release of VidaMed, Inc. issued February 7, 2002 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VIDAMED, INC. By: /s/ JOHN F. HOWE --------------------------------- John F. Howe Vice President, Finance and Chief Financial Officer Dated: February 19, 2002 VIDAMED, Inc. FORM 8-K Exhibit Index -------------
Exhibit No. Description Method of Filing ---------- ------------------------------------------------------- ----------------------- 99.1 Press Release of VidaMed, Inc. issued February 7, 2002 Filed herewith